Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders.

Ongoing coxsackievirus B3 (CVB3) myocarditis is characterized by persistence of viral RNA and chronic inflammation primarily mediated by macrophages and T cells. Activated macrophages produce anti-viral effector molecules comprising reactive nitrogen intermediates; however, reactive nitrogen intermediates also contribute to host tissue damage. Controlled activation of macrophages depends on interferon (IFN)-gamma and interleukin (IL)-10. To evaluate mechanisms involved in CVB3-induced pathogenesis of myocarditis, we determined the relationship of inducible nitric-oxide synthase (iNOS) mRNA expression with IFN-gamma and IL-10 secretion during CVB3 infection in different mouse strains. We found in susceptible A.BY/SnJ mice that develop ongoing myocarditis, a low and delayed IFN-gamma secretion and highly diminished IL-10 production compared with resistant C57BL/6 mice. Consequently, iNOS mRNA synthesis was delayed but clearly prolonged in susceptible mice. IL-10 gene-deficient mice confirmed the regulatory role of IL-10 in the outcome of CVB3 myocarditis. These mice did not establish a persistent cardiac infection and revealed IFN-gamma secretion kinetics similar to resistant mice but showed a slightly elongated cardiac iNOS mRNA expression resulting in extended myocarditis. We conclude that coordinated secretion of IFN-gamma and IL-10 is crucial for the effective resolution of CVB3 myocarditis. Moreover, lack of regulatory IL-10 leads to uncontrolled iNOS mRNA production, thus contributing to ongoing myocardial injury.

[1]  P. Tripathi Nitric oxide and immune response. , 2007, Indian journal of biochemistry & biophysics.

[2]  R. Zell,et al.  Interferon-gamma-induced activation of nitric oxide-mediated antiviral activity of macrophages caused by a recombinant coxsackievirus B3. , 2005, Viral immunology.

[3]  N. Rose,et al.  IL-12 Protects against Coxsackievirus B3-Induced Myocarditis by Increasing IFN-γ and Macrophage and Neutrophil Populations in the Heart1 , 2005, The Journal of Immunology.

[4]  S. Palaniyandi,et al.  Inhibition of mast cells by interleukin‐10 gene transfer contributes to protection against acute myocarditis in rats , 2004, European journal of immunology.

[5]  T. Yajima,et al.  Interleukin-10: biomarker or pathologic cytokine in fulminant myocarditis? , 2004, Journal of the American College of Cardiology.

[6]  I. Takeuchi,et al.  Serum levels of interleukin-10 on admission as a prognostic predictor of human fulminant myocarditis. , 2004, Journal of the American College of Cardiology.

[7]  K. Klingel,et al.  Molecular pathology of inflammatory cardiomyopathy , 2004, Medical Microbiology and Immunology.

[8]  K. Klingel,et al.  beta2-microglobulin-associated regulation of interferon-gamma and virus-specific immunoglobulin G confer resistance against the development of chronic coxsackievirus myocarditis. , 2003, The American journal of pathology.

[9]  I. Kerr,et al.  The Antiviral Response to Gamma Interferon , 2002, Journal of Virology.

[10]  F. Leuschner,et al.  Cutting Edge: A Critical Role for IL-10 in Induction of Nasal Tolerance in Experimental Autoimmune Myocarditis1 , 2002, The Journal of Immunology.

[11]  J. Miyazaki,et al.  Protection Against Autoimmune Myocarditis by Gene Transfer of Interleukin-10 by Electroporation , 2001, Circulation.

[12]  R. Zell,et al.  Expression of Immunoregulatory Cytokines by Recombinant Coxsackievirus B3 Variants Confers Protection against Virus-Caused Myocarditis , 2001, Journal of Virology.

[13]  D. Gemsa,et al.  Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice. , 2001, Journal of molecular and cellular cardiology.

[14]  D. Gemsa,et al.  Suppression of proinflammatory cytokines and induction of IL‐10 in human monocytes after coxsackievirus B3 infection , 2001, Journal of medical virology.

[15]  S Sasayama,et al.  Cytokine gene therapy for myocarditis by in vivo electroporation. , 2001, Human gene therapy.

[16]  S. Marsch,et al.  Lethal Autoimmune Myocarditis in Interferon-&ggr; Receptor–Deficient Mice: Enhanced Disease Severity by Impaired Inducible Nitric Oxide Synthase Induction , 2001, Circulation.

[17]  R. Rhoads,et al.  Nitric Oxide Inhibits Dystrophin Proteolysis by Coxsackieviral Protease 2A Through S-Nitrosylation: A Protective Mechanism Against Enteroviral Cardiomyopathy , 2000, Circulation.

[18]  N. Sarvetnick,et al.  Pancreatic expression of interferon-γ protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis , 2000, Nature Medicine.

[19]  F. Rodríguez,et al.  The role of B lymphocytes in coxsackievirus B3 infection. , 1999, The American journal of pathology.

[20]  T. Mak,et al.  Susceptibility to Myocarditis Is Dependent on the Response of αβ T Lymphocytes to Coxsackieviral Infection , 1999 .

[21]  A. Matsumori,et al.  Treatment of experimental viral myocarditis with interleukin-10. , 1999, Circulation.

[22]  Zhang,et al.  Induction of myocardial nitric oxide synthase by Coxsackie B3 virus in mice , 1999, European journal of clinical investigation.

[23]  F. Marumo,et al.  Nitric oxide induces apoptotic death of cardiomyocytes via a cyclic-GMP-dependent pathway. , 1999, Experimental cell research.

[24]  C. Lowenstein,et al.  The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  C. Lowenstein,et al.  Nitric oxide inhibition of coxsackievirus replication in vitro. , 1997, The Journal of clinical investigation.

[26]  Y. Yazaki,et al.  Expression of cytokine mRNAs in murine hearts with acute myocarditis caused by coxsackievirus B3 , 1997, The Journal of pathology.

[27]  P. Efron,et al.  Nitric oxide, an autocrine regulator of wound fibroblast synthetic function. , 1997, Journal of immunology.

[28]  J S Beckman,et al.  Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.

[29]  J. Whitton,et al.  The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis , 1995, Journal of virology.

[30]  M. Radomski,et al.  Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart disease. , 1995, British heart journal.

[31]  T. Martino,et al.  Viral infection and the pathogenesis of dilated cardiomyopathy. , 1994, Circulation research.

[32]  P. Hofschneider,et al.  Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[33]  N. Rose,et al.  Interferon- Protects against Chronic Viral Myocarditis by Reducing Mast Cell Degranulation, Fibrosis, and the Profibrotic Cytokines Transforming Growth Factor- 1, Interleukin-1 , and Interleukin-4 in the Heart , 2004 .

[34]  N. Rose,et al.  Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart. , 2004, The American journal of pathology.

[35]  K. Klingel,et al.  Pathogenesis of Coxsackievirus В Infections , 2002 .

[36]  B. Semler,et al.  Molecular biology of picornaviruses , 2002 .

[37]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[38]  T. Mak,et al.  Susceptibility to myocarditis is dependent on the response of alphabeta T lymphocytes to coxsackieviral infection. , 1999, Circulation research.

[39]  K. Klingel,et al.  Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[40]  B. McManus,et al.  Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[41]  M. Capobianchi,et al.  Role of interferon in lethality and lymphoid atrophy induced by Coxsackievirus B3 infection in mice. , 1991, Viral immunology.

[42]  H. Arizpe,et al.  Characterization of the antibody response in vaccinated mice protected against Coxsackievirus B3-induced myocarditis. , 1987, Viral immunology.